174073-19-9Relevant articles and documents
PREMATURE OVULATION PREVENTIVE AGENT
-
Page/Page column 31, (2008/12/04)
The present invention provides a premature ovulation inhibitor for use in in vitro fertilization or embryo transfer process, which contains a nonpeptidic compound having a gonadotropin releasing hormone antagonistic action. The premature ovulation inhibitor for use in in vitro fertilization or embryo transfer process of the present invention is low toxic, permits oral administration, and has a superior inhibitory effect on premature ovulation in in vitro fertilization or embryo transfer process.
MEDICINAL SOLUTIONS
-
, (2008/06/13)
The present invention relates to a pharmaceutical solution containing a physiologically active non-peptide substance, an organic acid and a biocompatible organic solvent, and provides a pharmaceutical solution wherein a physiologically active non-peptide
Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists
Guo, Zhiqiang,Chen, Yongsheng,Wu, Dongpei,Zhu, Yun-Fei,Struthers, R. Scott,Saunders, John,Xie, Qiu,Chen, Chen
, p. 3617 - 3622 (2007/10/03)
The synthesis and SAR studies of thieno[2,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonists to treat reproductive diseases are discussed. It was found that the 2-(2-pyridyl)ethyl group on the 5-aminomethyl functionality of the core structure wa